What it sells
Absorbable wrap for blood vessels
Business model breakdown
Buyer: who owns the budget?
UnverifiedHospitals and vascular surgery/dialysis access programs (surgeon-driven purchase) once cleared; not yet for sale.
Trigger: what makes them buy now?
50-60% of dialysis access sites fail in the first year; access failures cost Medicare $4B+ per year.
Workflow: what inputs become what output?
Surgeon places the bioabsorbable SelfWrap perivascular wrap around the AV access site at the time of AV creation surgery; it supports the vein and is absorbed by the body.
Economics: what it saves and how it charges
Pre-revenue clinical-stage medical device company; SelfWrap is investigational and not available for sale in any country.
Distribution: how it reaches customers
No commercial channel yet; the site recruits patients and sites to a clinical trial.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Summer 2020 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.